Role of modern neoadjuvant chemoradiotherapy in locally advanced thymic epithelial neoplasms.
Yirui ZhaiDazhi ChenYushun GaoZhouguang HuiLiyan XueZongmei ZhouYang LuoZefen XiaoQin-Fu FengPublished in: Tumori (2020)
For patients with primary unresectable thymic neoplasms, neoadjuvant chemoradiotherapy is an efficient and safe choice, with favorable response and survival and moderate toxicities. Patients with thymic carcinoma might benefit more from neoadjuvant therapies.